Semiconductors
Compare Stocks
5 / 10Stock Comparison
AEHR vs ACLS vs ONTO vs COHU vs FORM
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
AEHR vs ACLS vs ONTO vs COHU vs FORM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $2.79B | $4.88B | $13.63B | $2.23B | $11.28B |
| Revenue (TTM) | $49M | $845M | $1.03B | $481M | $840M |
| Net Income (TTM) | $-11M | $101M | $106M | $-56M | $68M |
| Gross Margin | 30.2% | 43.6% | 48.8% | 25.7% | 42.1% |
| Operating Margin | -27.8% | 11.6% | 10.0% | -10.6% | 12.7% |
| Forward P/E | — | 43.5x | 38.7x | 89.2x | 66.5x |
| Total Debt | $11M | $42M | $17M | $359M | $45M |
| Cash & Equiv. | $25M | $145M | $346M | $227M | $103M |
AEHR vs ACLS vs ONTO vs COHU vs FORM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Aehr Test Systems (AEHR) | 100 | 5530.9 | +5430.9% |
| Axcelis Technologie… (ACLS) | 100 | 590.9 | +490.9% |
| Onto Innovation Inc. (ONTO) | 100 | 881.7 | +781.7% |
| Cohu, Inc. (COHU) | 100 | 315.3 | +215.3% |
| FormFactor, Inc. (FORM) | 100 | 574.8 | +474.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AEHR vs ACLS vs ONTO vs COHU vs FORM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AEHR is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 70.3% 10Y total return vs FORM's 19.5%
- +9.9% vs ONTO's +118.9%
ACLS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 2.00
- Lower volatility, beta 2.00, Low D/E 4.1%, current ratio 4.77x
- 11.9% margin vs AEHR's -22.7%
- Beta 2.00 vs AEHR's 4.77, lower leverage
ONTO ranks third and is worth considering specifically for valuation efficiency.
- PEG 1.12 vs ACLS's 2.06
- Lower P/E (38.7x vs 66.5x)
COHU is the clearest fit if your priority is growth exposure and defensive.
- Rev growth 12.7%, EPS growth -6.7%, 3Y rev CAGR -17.7%
- Beta 2.13, current ratio 6.88x
- 12.7% revenue growth vs AEHR's -20.2%
Among these 5 stocks, FORM doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.7% revenue growth vs AEHR's -20.2% | |
| Value | Lower P/E (38.7x vs 66.5x) | |
| Quality / Margins | 11.9% margin vs AEHR's -22.7% | |
| Stability / Safety | Beta 2.00 vs AEHR's 4.77, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +9.9% vs ONTO's +118.9% | |
| Efficiency (ROA) | 7.5% ROA vs AEHR's -7.5%, ROIC 9.6% vs -3.0% |
AEHR vs ACLS vs ONTO vs COHU vs FORM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AEHR vs ACLS vs ONTO vs COHU vs FORM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FORM leads in 1 of 6 categories
ACLS leads 1 • AEHR leads 1 • ONTO leads 0 • COHU leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FORM leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ONTO is the larger business by revenue, generating $1.0B annually — 21.0x AEHR's $49M. ACLS is the more profitable business, keeping 11.9% of every revenue dollar as net income compared to AEHR's -22.7%. On growth, FORM holds the edge at +32.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $49M | $845M | $1.0B | $481M | $840M |
| EBITDAEarnings before interest/tax | -$10M | $111M | $158M | -$11M | $152M |
| Net IncomeAfter-tax profit | -$11M | $101M | $106M | -$56M | $68M |
| Free Cash FlowCash after capex | -$14M | $90M | $239M | $32M | -$5M |
| Gross MarginGross profit ÷ Revenue | +30.2% | +43.6% | +48.8% | +25.7% | +42.1% |
| Operating MarginEBIT ÷ Revenue | -27.8% | +11.6% | +10.0% | -10.6% | +12.7% |
| Net MarginNet income ÷ Revenue | -22.7% | +11.9% | +10.3% | -11.5% | +8.1% |
| FCF MarginFCF ÷ Revenue | -28.1% | +10.7% | +23.2% | +6.6% | -0.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -26.5% | +3.3% | +9.5% | +29.3% | +32.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.2% | -65.9% | -48.5% | +60.6% | +2.2% |
Valuation Metrics
Evenly matched — ACLS and ONTO and COHU each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 41.8x trailing earnings, ACLS trades at a 80% valuation discount to FORM's 209.7x P/E. Adjusting for growth (PEG ratio), ACLS offers better value at 1.98x vs ONTO's 2.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.8B | $4.9B | $13.6B | $2.2B | $11.3B |
| Enterprise ValueMkt cap + debt − cash | $2.8B | $4.8B | $13.3B | $2.4B | $11.2B |
| Trailing P/EPrice ÷ TTM EPS | -702.00x | 41.75x | 98.57x | -29.86x | 209.68x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 43.49x | 38.74x | 89.21x | 66.48x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.98x | 2.85x | — | — |
| EV / EBITDAEnterprise value multiple | — | 34.85x | 68.79x | — | 100.94x |
| Price / SalesMarket cap ÷ Revenue | 47.39x | 5.81x | 13.56x | 4.93x | 14.37x |
| Price / BookPrice ÷ Book value/share | 21.97x | 4.86x | 6.43x | 2.82x | 10.94x |
| Price / FCFMarket cap ÷ FCF | — | 45.56x | 45.47x | 207.83x | 960.69x |
Profitability & Efficiency
ACLS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ACLS delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-8 for AEHR. ONTO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to COHU's 0.46x. On the Piotroski fundamental quality scale (0–9), ACLS scores 5/9 vs AEHR's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.5% | +9.8% | +5.2% | -6.8% | +6.7% |
| ROA (TTM)Return on assets | -7.5% | +7.5% | +4.7% | -4.9% | +5.6% |
| ROICReturn on invested capital | -3.0% | +9.6% | +5.7% | -5.7% | +5.4% |
| ROCEReturn on capital employed | -3.2% | +10.4% | +6.5% | -5.9% | +6.1% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 5 | 4 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.09x | 0.04x | 0.01x | 0.46x | 0.04x |
| Net DebtTotal debt minus cash | -$14M | -$103M | -$329M | $132M | -$58M |
| Cash & Equiv.Liquid assets | $25M | $145M | $346M | $227M | $103M |
| Total DebtShort + long-term debt | $11M | $42M | $17M | $359M | $45M |
| Interest CoverageEBIT ÷ Interest expense | — | 77.10x | — | -168.82x | 252.69x |
Total Returns (Dividends Reinvested)
AEHR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AEHR five years ago would be worth $398,515 today (with dividends reinvested), compared to $12,218 for COHU. Over the past 12 months, AEHR leads with a +991.6% total return vs ONTO's +118.9%. The 3-year compound annual growth rate (CAGR) favors FORM at 72.9% vs ACLS's 9.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +311.8% | +84.2% | +65.2% | +92.9% | +144.4% |
| 1-Year ReturnPast 12 months | +991.6% | +173.2% | +118.9% | +199.7% | +387.8% |
| 3-Year ReturnCumulative with dividends | +242.3% | +32.2% | +218.0% | +40.7% | +417.3% |
| 5-Year ReturnCumulative with dividends | +3885.1% | +286.8% | +312.6% | +22.2% | +273.9% |
| 10-Year ReturnCumulative with dividends | +7029.7% | +1505.9% | +1431.7% | +330.2% | +1952.2% |
| CAGR (3Y)Annualised 3-year return | +50.7% | +9.7% | +47.1% | +12.1% | +72.9% |
Risk & Volatility
Evenly matched — ACLS and COHU each lead in 1 of 2 comparable metrics.
Risk & Volatility
ACLS is the less volatile stock with a 2.00 beta — it tends to amplify market swings less than AEHR's 4.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. COHU currently trades 93.7% from its 52-week high vs ONTO's 86.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 4.77x | 2.00x | 2.66x | 2.13x | 2.02x |
| 52-Week HighHighest price in past year | $102.48 | $171.60 | $315.86 | $50.68 | $159.09 |
| 52-Week LowLowest price in past year | $8.06 | $55.81 | $85.88 | $15.34 | $26.08 |
| % of 52W HighCurrent price vs 52-week peak | +89.1% | +92.5% | +86.8% | +93.7% | +90.9% |
| RSI (14)Momentum oscillator 0–100 | 67.6 | 84.4 | 61.0 | 75.5 | 66.5 |
| Avg Volume (50D)Average daily shares traded | 3.0M | 734K | 832K | 953K | 1.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: AEHR as "Hold", ACLS as "Buy", ONTO as "Buy", COHU as "Buy", FORM as "Hold". Consensus price targets imply 12.5% upside for ONTO (target: $308) vs -32.1% for AEHR (target: $62).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $62.00 | $128.00 | $308.33 | $49.75 | $123.38 |
| # AnalystsCovering analysts | 3 | 12 | 11 | 14 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | — | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | +2.5% | +0.6% | +0.3% | +0.2% |
FORM leads in 1 of 6 categories (Income & Cash Flow). ACLS leads in 1 (Profitability & Efficiency). 2 tied.
AEHR vs ACLS vs ONTO vs COHU vs FORM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AEHR or ACLS or ONTO or COHU or FORM a better buy right now?
For growth investors, Cohu, Inc.
(COHU) is the stronger pick with 12. 7% revenue growth year-over-year, versus -17. 6% for Axcelis Technologies, Inc. (ACLS). Axcelis Technologies, Inc. (ACLS) offers the better valuation at 41. 8x trailing P/E (43. 5x forward), making it the more compelling value choice. Analysts rate Axcelis Technologies, Inc. (ACLS) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AEHR or ACLS or ONTO or COHU or FORM?
On trailing P/E, Axcelis Technologies, Inc.
(ACLS) is the cheapest at 41. 8x versus FormFactor, Inc. at 209. 7x. On forward P/E, Onto Innovation Inc. is actually cheaper at 38. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Onto Innovation Inc. wins at 1. 12x versus Axcelis Technologies, Inc. 's 2. 06x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AEHR or ACLS or ONTO or COHU or FORM?
Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +38.
9%, compared to +22. 2% for Cohu, Inc. (COHU). Over 10 years, the gap is even starker: AEHR returned +70. 3% versus COHU's +330. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AEHR or ACLS or ONTO or COHU or FORM?
By beta (market sensitivity over 5 years), Axcelis Technologies, Inc.
(ACLS) is the lower-risk stock at 2. 00β versus Aehr Test Systems's 4. 77β — meaning AEHR is approximately 139% more volatile than ACLS relative to the S&P 500. On balance sheet safety, Onto Innovation Inc. (ONTO) carries a lower debt/equity ratio of 1% versus 46% for Cohu, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AEHR or ACLS or ONTO or COHU or FORM?
By revenue growth (latest reported year), Cohu, Inc.
(COHU) is pulling ahead at 12. 7% versus -17. 6% for Axcelis Technologies, Inc. (ACLS). On earnings-per-share growth, the picture is similar: Aehr Test Systems grew EPS 0. 0% year-over-year, compared to -38. 2% for Axcelis Technologies, Inc.. Over a 3-year CAGR, AEHR leads at 5. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AEHR or ACLS or ONTO or COHU or FORM?
Axcelis Technologies, Inc.
(ACLS) is the more profitable company, earning 14. 3% net margin versus -16. 4% for Cohu, Inc. — meaning it keeps 14. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACLS leads at 14. 2% versus -13. 3% for COHU. At the gross margin level — before operating expenses — ONTO leads at 49. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AEHR or ACLS or ONTO or COHU or FORM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Onto Innovation Inc. (ONTO) is the more undervalued stock at a PEG of 1. 12x versus Axcelis Technologies, Inc. 's 2. 06x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Onto Innovation Inc. (ONTO) trades at 38. 7x forward P/E versus 89. 2x for Cohu, Inc. — 50. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ONTO: 12. 5% to $308. 33.
08Which pays a better dividend — AEHR or ACLS or ONTO or COHU or FORM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is AEHR or ACLS or ONTO or COHU or FORM better for a retirement portfolio?
For long-horizon retirement investors, Axcelis Technologies, Inc.
(ACLS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1506% 10Y return). Aehr Test Systems (AEHR) carries a higher beta of 4. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACLS: +1506%, AEHR: +70. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AEHR and ACLS and ONTO and COHU and FORM?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.